EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Immunization against rabies using a recombinant vaccinia virus expressing the rabies glycoprotein






Genetical Research 45(2): 213

Immunization against rabies using a recombinant vaccinia virus expressing the rabies glycoprotein


(PDF 0-2 workdays service: $29.90)

Accession: 028475523



Related references

Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein. Archives of Virology 102(3-4): 297-301, 1988

Immunization against rabies using a vaccinia-rabies recombinant virus expressing the surface glycoprotein. Vaccines 85: molecular and chemical basis of resistance to parasitic bacterial and viral diseases edited by Richard A Lerner Robert M Chanock Fred Brown: 162, 1985

Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Vaccine 22(25/26): 3329-3333, 2004

Development of an oral wildlife rabies vaccine immunization of raccoons by a vaccinia rabies glycoprotein recombinant virus and preliminary field baiting trials. Chanock, R M , Et Al (Ed ) Vaccines, 87 Modern Approaches to New Vaccines: Prevention Of Aids And Other Viral, Bacterial, And Parasitic Diseases; Conference, Cold Spring Harbor, New York, Usa, 1986 Xxiii+461p Cold Spring Harbor Laboratory: Cold Spring Harbor, New York, Usa Illus Paper 389-392, 1987

Immunogenic properties of vaccinia recombinant virus expressing the rabies glycoprotein. Annales de l'Institut Pasteur Virology 136E(4): 405-412, 1985

NYVAC-RG a highly attenuated vaccinia recombinant expressing the rabies G glycoprotein is safe and induces high titers of rabies neutralizing antibodies in adult volunteers. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35(0): 190, 1995

Construction and characterization of non-replicating recombinant vaccinia virus expressing rabies glycoprotein. Zhonghua Shi Yan He Lin Chuang Bing du Xue Za Zhi 13(2): 170-174, 2003

Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein. Journal of Virology 66(5): 2601-2604, 1992

Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine 12(15): 1368-1371, 1994

New generation of rabies vaccine. Vaccinia-rabies glycoprotein recombinant virus. Applied Virology Research, Volume 1 New Vaccines and Chemotherapy: 69-90, 1988